Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|62|12|3827-3829

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3827-3829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure

By Fransen Jaap Kooloos Wouter M Wessels Judith AM Huizinga Tom WJ Guchelaar Henk-Jan van Riel Piet LCM Barrera Pilar

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1087-1094

Future Medicine

Access to resources Recommend Favorite

Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis

By Tilling Lindsey Townsend Sue David Joel

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 55-62

Adis International

Access to resources Recommend Favorite

Associations between the C677T and A1298C Polymorphisms of MTHFR and the Efficacy and Toxicity of Methotrexate in Rheumatoid Arthritis: A Meta-Analysis

By > >

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Sulfasalazine + methotrexate beneficial for rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Methotrexate improves survival in rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite